Skip to content

Psychoeducational Intervention for Patients With Hepatocellular Carcinoma

HARMONY: A Psychoeducational Intervention to Reduce Psychological Distress and Improve Quality of Life for Patients With Hepatocellular Carcinoma

Status
Recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06541990
Acronym
HARMONY
Enrollment
50
Registered
2024-08-07
Start date
2024-10-28
Completion date
2026-09-30
Last updated
2025-08-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hepatocellular Carcinoma

Brief summary

This study aims to refine and pilot test HARMONY, a psychoeducational intervention for patients with newly diagnosed hepatocellular carcinoma (HCC).

Detailed description

There are two parts of this study. Study Part 1 is an open pilot study to refine HARMONY prior to larger-scale testing in a randomized controlled trial (RCT) setting. Study Part 1 is purely descriptive, as the investigators will use the data to refine HARMONY before proceeding to Study Part 2. Study Part 2 is a pilot RCT to assess the feasibility and acceptability of conducting a randomized trial of HARMONY versus enhanced usual care. Participants will complete a baseline survey and then be randomized to HARMONY versus enhanced usual care (a supportive care resource guide). This record reflects the clinical trial component (Study Part 2), as feasibility and acceptability outcomes will be collected for this phase only.

Interventions

BEHAVIORALHARMONY

A psychoeducational intervention for patients with HCC

OTHEREnhanced usual care

A supportive care resource guide

Sponsors

Massachusetts General Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Age ≥18 years * New diagnosis of HCC within the last six months * Ability to complete study procedures English

Exclusion criteria

* Incidentally diagnosed with HCC after liver transplantation * Significant uncontrolled hepatic encephalopathy, cognitive impairment, or psychiatric disorder which will interfere with study participation * Patients near the end of life for whom hospice is recommended

Design outcomes

Primary

MeasureTime frameDescription
Feasibility: study enrollment rate10 weeks≥40% enrollment among consecutive eligible patients

Secondary

MeasureTime frameDescription
Feasibility: intervention completion rate10 weeks≥50% completion of 2/3 intervention sessions in the HARMONY arm
Acceptability10 weeks≥70% of patients in the HARMONY arm reporting Client Satisfaction Questionnaire-8 (CSQ-8) scores at or above the midpoint score of 20 on a scale from 8-32

Countries

United States

Contacts

Primary ContactKelsey Lau-Min
klau-min@mgh.harvard.edu617-724-4000

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026